Oregon station didn't report that McDonald's, Moderna teamed up | Fact check
A director at Portland's KGW-TV said the station did not publish that report. There is no evidence the companies partnered on ...
Hosted on MSN1d
Down 60% in 3 Years, Will Moderna Stock (NASDAQ:MRNA) Fall Further?
Moderna (NASDAQ:MRNA) stock is now down 3% over the past 12 months and down 60% in the past three years. It surged in late ...
STAT4d
Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund
Drug development has languished despite the burden of heart disease. Cardurion has two drug candidates in mid-stage clinical ...
Is Moderna Stock a Buy?
Moderna's mRNA platform now features a long list of candidates, and the biotech still has enough cash on hand -- $12.2 ...
How companies like Moderna, Takeda are riding AI hype
Local life sciences companies like Moderna Inc. and Takeda Pharmaceuticals Inc. are leaning into AI to help employees work ...
The Motley Fool: Moderna’s biotechnology advances are quite promising
Moderna has won U.S. Food and Drug Administration approval for its respiratory syncytial virus vaccine mResvia, ushering in a new era for the ...
justthenews11d
FDA blesses departing COVID vaccine reviewers to influence agency 'behind the scenes' at Moderna
Agency defends practice as lawful, emphasizes ex-employees still subject to 'certain restrictions under the ethics law.' FDA ...
Incyte, Moderna among most shorted S&P 500 healthcare stocks in June
Short percentage in S&P 500 healthcare companies rose slightly at the end of June, with biotechnology emerging as most ...
Benzinga.com2d
Decoding Moderna's Options Activity: What's the Big Picture?
Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna. Looking at options history for Moderna MRNA we detected 8 trades. If we consider the specifics of each trade, ...
Yahoo Finance1d
Moderna (NASDAQ:MRNA) shareholders have earned a 54% CAGR over the last five years
While not every stock performs well, when investors win, they can win big. To wit, the Moderna, Inc. (NASDAQ:MRNA) share price has soared 758% over five years. If that doesn't get you thinking about ...